Henry ScheinHSIC +1.01%81 Forward PE Ratio is 15.96 as of Jul. 13, 2026. GuruFocus rates HSIC with a GF Score™ of 81/100 and a GF Value™ of $83.91 (Fairly Valued). The stock has 9 warning signs investors should review. Among 51 Medical Distribution companies, Henry Schein ranks worse than 62.75% on this metric.
Henry Schein's Forward PE Ratio for today is 15.96.
Henry Schein (NAS:HSIC) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Henry Schein Forward PE Ratio Related Terms
Henry Schein Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Henry Schein's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein Forward PE Ratio Chart
Henry Schein Annual Data
Trend
2015-12
2016-12
2017-12
2018-12
2019-12
2020-12
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
23.92
20.92
17.86
17.64
17.99
17.61
16.78
15.95
14.71
13.59
14.38
Henry Schein Quarterly Data
2015-12
2016-03
2016-06
2016-09
2016-12
2017-03
2017-06
2017-09
2017-12
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
23.92
22.88
25.77
22.37
20.92
23.42
25.45
20.24
17.86
16.50
17.79
19.34
17.64
17.18
20.12
16.53
17.99
13.51
25.51
16.81
17.61
18.32
20.08
17.70
16.78
18.12
15.80
12.72
15.95
15.27
15.48
12.89
14.71
14.93
12.80
13.93
13.59
14.09
15.02
12.66
14.38
13.62
HSIC vs AHG, ACH, FOCL: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Henry Schein's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Henry Schein's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Henry Schein (HSIC) has a Forward PE Ratio of 15.96 as of Jul. 13, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Henry Schein and its competitors. According to the industry distribution chart, Henry Schein ranks #32 out of 51 companies in the Medical Distribution industry, placing it in the top 62.7%.
Is Henry Schein's Forward PE Ratio too high?
Henry Schein's current Forward PE Ratio is 15.96. The Medical Distribution industry median Forward PE Ratio is 14.53. Henry Schein's value of 15.96 is 9.8% above this industry median. Based on the distribution chart, Henry Schein ranks #32 out of 51 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Henry Schein has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's Forward PE Ratio compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #32 out of 51 companies for Forward PE Ratio. This places Henry Schein in the lower half of its industry. The industry median Forward PE Ratio is 14.53. Henry Schein's value of 15.96 is 9.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.53, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current Forward PE Ratio of 15.96 is 9.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current Forward PE Ratio is 15.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.91, compared to a current price of $85.25 — trading 1.6% above its estimated fair value. The current Forward PE Ratio is 15.96 and 9.8% above the Medical Distribution industry median of 14.53. Henry Schein's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Henry Schein (HSIC), the current Forward PE Ratio is 15.96 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $85.25 is trading 1.6% above its estimated GF Value™ of $83.91.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
Forward PE Ratio: 15.96
GF Value™: $83.91 vs. price of $85.25 (1.6% above fair value)
Industry Position: 9.8% above the Medical Distribution median (#32 of 51)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
81GF Score
Get the complete analysis for HSIC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 